Trade Precision BioSciences, Inc. - DTIL CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.1516 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 4.8942 |
| Open | 4.8242 |
| 1-Year Change | 1187.48% |
| Day's Range | 4.5142 - 4.9042 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 21, 2025 | 4.5342 | -0.3400 | -6.98% | 4.8742 | 4.9442 | 4.5142 |
| Jan 17, 2025 | 4.8942 | 0.2200 | 4.71% | 4.6742 | 4.9842 | 4.5742 |
| Jan 16, 2025 | 4.6942 | -0.5100 | -9.80% | 5.2042 | 5.2742 | 4.6842 |
| Jan 15, 2025 | 5.1942 | -0.1700 | -3.17% | 5.3642 | 5.4242 | 5.0742 |
| Jan 14, 2025 | 5.3542 | -0.3800 | -6.63% | 5.7342 | 5.7442 | 5.2242 |
| Jan 13, 2025 | 5.7142 | 0.1100 | 1.96% | 5.6042 | 5.9642 | 5.0742 |
| Jan 10, 2025 | 5.6842 | -1.0900 | -16.09% | 6.7742 | 7.2942 | 5.2442 |
| Jan 8, 2025 | 4.4742 | -0.2700 | -5.69% | 4.7442 | 4.7442 | 4.4442 |
| Jan 7, 2025 | 4.7642 | 0.0500 | 1.06% | 4.7142 | 4.8342 | 4.4942 |
| Jan 6, 2025 | 4.6842 | -0.0900 | -1.89% | 4.7742 | 4.9042 | 4.6042 |
| Jan 3, 2025 | 4.7242 | -0.0200 | -0.42% | 4.7442 | 4.8142 | 4.5642 |
| Jan 2, 2025 | 4.6842 | 0.7100 | 17.87% | 3.9742 | 4.9642 | 3.9742 |
| Dec 31, 2024 | 3.7742 | -0.5200 | -12.11% | 4.2942 | 4.4442 | 3.5742 |
| Dec 30, 2024 | 4.2742 | -0.3000 | -6.56% | 4.5742 | 4.5842 | 4.1842 |
| Dec 27, 2024 | 4.5842 | -0.1000 | -2.13% | 4.6842 | 4.8242 | 4.5742 |
| Dec 26, 2024 | 4.6842 | 0.2100 | 4.69% | 4.4742 | 4.7442 | 4.4642 |
| Dec 24, 2024 | 4.4742 | 0.0500 | 1.13% | 4.4242 | 4.5542 | 4.4142 |
| Dec 23, 2024 | 4.4742 | -0.0900 | -1.97% | 4.5642 | 4.9342 | 4.4742 |
| Dec 20, 2024 | 4.6842 | 0.2500 | 5.64% | 4.4342 | 4.9542 | 4.4342 |
| Dec 19, 2024 | 4.5742 | 0.2700 | 6.27% | 4.3042 | 4.6242 | 4.2242 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Precision BioSciences, Inc. Company profile
About Precision BioSciences Inc
Precision BioSciences, Inc is a clinical stage biotechnology company. The Company’s ARCUS platform is designed to deliver therapeutic-grade genome editing. Its ARCUS genome editing technology is for deoxyribonucleic acid (DNA) genome insertion, deletion and repair. Its ARCUS is based on a naturally occurring genome editing enzyme, I-CreI, that evolved in the algae Chlamydomonas reinhardtii to make specific cuts and DNA insertions in cellular DNA. The Company’s pipeline includes Ex vivo Allogeneic CAR T Immunotherapy and In vivo Gene Correction. Its Ex vivo Allogeneic CAR T Immunotherapy pipeline offers programs, including PBCAR0191, PBCAR19B, PBCAR269A and CD19 Combination with Foralumab. Its in-vivo Gene Correction pipeline offers three preclinical programs, including PBGENE-PCSK9, PBGENE-PH1 and PBGENE-HBV. The Company’s subsidiaries include Precision PlantSciences, Inc. and Precision BioSciences UK Limited.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Precision BioSciences Inc revenues increased from $24.3M to $115.5M. Net loss decreased 72% to $30.6M. Revenues reflect Therapeutics segment increase from $21.9M to $111.7M, Food segment increase of 57% to $3.8M. Lower net loss reflects Therapeutics segment income totaling $32M vs. loss of $50M, Food segment loss decrease of 26% to $3.8M.
| Industry: | Biotechnology & Medical Research (NEC) |
302 E Pettigrew St Ste A100
DURHAM
NORTH CAROLINA 27701-2393
US
News
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
15:24, 21 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024People also watch
Still looking for a broker you can trust?
Join the 680,000+ traders worldwide that chose to trade with Capital.com